Hydroxyurea and sickle cell leg ulcers
โ Scribed by Colleen Kersgard; Michael B. Osswald
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 62 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0361-8609
- DOI
- 10.1002/ajh.1183
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The Multicenter Study of Hydroxyurea in Sickle Cell Anemia (MSH) demonstrated the efficacy of hydroxyurea in reducing the rate of painful crises compared to placebo. We used resource utilization data collected in the MSH to determine the cost-effectiveness of hydroxyurea. The MSH was a randomized, p
Use of hydroxyurea (HU) to treat sickle cell disease is usually associated with increments in fetal hemoglobin (Hb F) production; however, in vitro studies show that HU may also induce hemoglobin denaturation. Whole blood samples from Hb AA, Hb AS, and Hb SS patients were treated in vitro with 100,